Evidence map›Paper›PMID 33575361›Full record

ArticleJournal of immunology research2021

Chinese Traditional Medicine NiuBeiXiaoHe (NBXH) Extracts Have the Function of Antituberculosis and Immune Recovery in BALB/c Mice.

Yan Liang, Wenping Gong, Xiaomei Wang, Junxian Zhang, Yanbo Ling, Jinying Song, Lan Wang, Xiao Liu, Jie Wang, Yourong Yang and 5 more

Open access · goldAbstract read
In one paragraph

Article in Journal of immunology research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Yan Liang *Army Tuberculosis Prevention and Control Key Laboratory/Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Institute of Tuberculosis Research, The 8th Medical Centre of Chinese PLA General Hospital, Beijing 100091, China.
Wenping Gong *Army Tuberculosis Prevention and Control Key Laboratory/Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Institute of Tuberculosis Research, The 8th Medical Centre of Chinese PLA General Hospital, Beijing 100091, China.ORCID https://orcid.org/0000-0002-0333-890X
Xiaomei Wang *Army Tuberculosis Prevention and Control Key Laboratory/Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Institute of Tuberculosis Research, The 8th Medical Centre of Chinese PLA General Hospital, Beijing 100091, China.
Junxian Zhang *Army Tuberculosis Prevention and Control Key Laboratory/Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Institute of Tuberculosis Research, The 8th Medical Centre of Chinese PLA General Hospital, Beijing 100091, China.
Yanbo LingArmy Tuberculosis Prevention and Control Key Laboratory/Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Institute of Tuberculosis Research, The 8th Medical Centre of Chinese PLA General Hospital, Beijing 100091, China.
Jinying SongArmy Tuberculosis Prevention and Control Key Laboratory/Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Institute of Tuberculosis Research, The 8th Medical Centre of Chinese PLA General Hospital, Beijing 100091, China.
Lan WangArmy Tuberculosis Prevention and Control Key Laboratory/Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Institute of Tuberculosis Research, The 8th Medical Centre of Chinese PLA General Hospital, Beijing 100091, China.
Xiao LiuArmy Tuberculosis Prevention and Control Key Laboratory/Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Institute of Tuberculosis Research, The 8th Medical Centre of Chinese PLA General Hospital, Beijing 100091, China.
Jie WangArmy Tuberculosis Prevention and Control Key Laboratory/Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Institute of Tuberculosis Research, The 8th Medical Centre of Chinese PLA General Hospital, Beijing 100091, China.
Yourong YangArmy Tuberculosis Prevention and Control Key Laboratory/Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Institute of Tuberculosis Research, The 8th Medical Centre of Chinese PLA General Hospital, Beijing 100091, China.
Shibing ChenArmy Tuberculosis Prevention and Control Key Laboratory/Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Institute of Tuberculosis Research, The 8th Medical Centre of Chinese PLA General Hospital, Beijing 100091, China.
Jun LiuGuangdong Qifang Pharmaceutical Co., Ltd., Guangzhou 510075, China.
Chunwei YangGuangdong Qifang Pharmaceutical Co., Ltd., Guangzhou 510075, China.
Huafeng LuoGuangdong Qifang Pharmaceutical Co., Ltd., Guangzhou 510075, China.
Xueqiong WuArmy Tuberculosis Prevention and Control Key Laboratory/Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Institute of Tuberculosis Research, The 8th Medical Centre of Chinese PLA General Hospital, Beijing 100091, China.ORCID https://orcid.org/0000-0001-8894-1929
Chinese PLA General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Traditional Chinese Medicine NiuBeiXiaoHe (NBXH) is a valid antituberculosis (TB) prescription from the experience of clinical practice. However, the mechanism of NBXH extracts' immunotherapy has been poorly understood. Herein, the immunotherapeutic efficacy and the differentially expressed (DE) genes of NBXH extracts were evaluated and identified in BALB/c mice.

methodsThe total RNA was extracted from peripheral blood mononuclear cells, and the DE genes were identified by gene chip. The enrichment and signaling pathway analyses were performed using Gene Ontology (GO) and KEGG database.

resultsIt was shown that the treatment of NBXH extracts (high dose) significantly reduced mycobacteria loads and histopathological lesions in mice infected by

conclusionsTaken together, NBXH extracts not only efficiently decreased the mycobacteria loads but also balanced the immune disorders in mice. These new findings provide a fresh perspective for elucidating the immunotherapeutic mechanism of NBXH extracts and pointed out the direction for improving the treatment efficacy of NBXH extracts.

Indexed as

AnimalsAntitubercular AgentsBacterial LoadBiomarkersBiopsyComputational BiologyDisease Models, AnimalDisease SusceptibilityDrugs, Chinese HerbalFemaleGene Expression ProfilingGene OntologyImmunologic FactorsMedicine, Chinese TraditionalMiceMice, Inbred BALB CAntitubercular AgentsBiomarkersDrugs, Chinese HerbalImmunologic Factorsniubeixiaohe

Identifiers

PMID33575361
PMCPMC7857905
OpenAlexW3124101991

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.